Sublobar Resection, Radiofrequency Ablation or Radiotherapy in Stage I Non-Small Cell Lung Cancer | Zendy

Seyer Safi | Zendy; Geraldine Rauch | Zendy; Jan op den Winkel | Zendy; Josef Kunz | Zendy; Thomas Schneider | Zendy; Marc Bischof | Zendy; Claus Peter Heußel | Zendy; Peter E. Huber | Zendy; Felix J.F. Herth | Zendy; Hendrik Dienemann | Zendy; Hans Hoffmann | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Sublobar Resection, Radiofrequency Ablation or Radiotherapy in Stage I Non-Small Cell Lung Cancer

Author(s) -

Seyer Safi,

Geraldine Rauch,

Jan op den Winkel,

Josef Kunz,

Thomas Schneider,

Marc Bischof,

Claus Peter Heußel,

Peter E. Huber,

Felix J.F. Herth,

Hendrik Dienemann,

Hans Hoffmann

Publication year - 2015

Publication title -

respiration

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.264

H-Index - 81

eISSN - 1423-0356

pISSN - 0025-7931

DOI - 10.1159/000381555

Subject(s) - medicine , radiofrequency ablation , hazard ratio , confidence interval , radiation therapy , lung cancer , prospective cohort study , stage (stratigraphy) , proportional hazards model , clinical endpoint , confounding , surgery , oncology , ablation , clinical trial , paleontology , biology

The best therapy for patients with stage I non-small cell lung cancer (NSCLC) who are medically unfit for lobectomy or prefer not to undergo surgery has not yet been demonstrated.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research